808139-14-2

Basic information

• Product Name: S-[5-[[(2,3-dichlorophenyl)sulfonyl][[2-(trimeihylsilyl)ethoxy]methyl]amino]-6-methoxypyrazin-2-yl]-N-[(1,1-dimethylethoxy)carbonyl]-L-cysteine
• Synonyms: S-[5-[[(2,3-dichlorophenyl)sulfonyl][[2-(trimeihylsilyl)ethoxy]methyl]amino]-6-methoxypyrazin-2-yl]-N-[(1,1-dimethylethoxy)carbonyl]-L-cysteine
• CAS NO: 808139-14-2
• Molecular Weight: 683.706
• Mol File: 808139-14-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: S-[5-[[(2,3-dichlorophenyl)sulfonyl][[2-(trimeihylsilyl)ethoxy]methyl]amino]-6-methoxypyrazin-2-yl]-N-[(1,1-dimethylethoxy)carbonyl]-L-cysteine(CAS DataBase Reference)
• NIST Chemistry Reference: S-[5-[[(2,3-dichlorophenyl)sulfonyl][[2-(trimeihylsilyl)ethoxy]methyl]amino]-6-methoxypyrazin-2-yl]-N-[(1,1-dimethylethoxy)carbonyl]-L-cysteine(808139-14-2)
• EPA Substance Registry System: S-[5-[[(2,3-dichlorophenyl)sulfonyl][[2-(trimeihylsilyl)ethoxy]methyl]amino]-6-methoxypyrazin-2-yl]-N-[(1,1-dimethylethoxy)carbonyl]-L-cysteine(808139-14-2)

Safety Data

• Hazardous Substances Data: 808139-14-2(Hazardous Substances Data)

Upstream product

• 82417-45-6 dichlorobenzenesulfonyl chloride 
• 172749-96-1 N-[(tert-butoxy)carbonyl]-L-cysteine methyl ester 
• 566203-96-1 2,3-dichloro-N-(3,5-dichloro-2-pyrazinyl)benzenesulphonamide 
• 566203-62-1 2,3-dichloro-N-(5-chloro-3-methoxy-2-pyrazinyl)benzenesulphonamide 
• 566204-86-2 2,3-dichloro-N-(5-chloro-3-methoxypyrazin-2-yl)-N-[[2-(trimethylsilyl)ethoxy]methyl]benzenesulfonamide 
• 808139-13-1 S-[5-[[(2,3-dichlorophenyl)sulfonyl][[2-(trimeihylsilyl)ethoxy]methyl]amino]-6-methoxypyrazin-2-yl]-N-[(1,1-dimethylethoxy)carbonyl]-L-cysteine methyl ester 

Downstream Products

• 808139-15-3 [(1R)-2-amino-1-[[[5-[[(2,3-dichlorophenyl)sulfonyl][[2-(trimethylsilyl)ethoxy]methyl]amino]-6-methoxypyrazin-2-yl]thio]methyl]-2-oxoethyl]carbamic acid 1,1-dimethylethyl ester 

Relevant articles and documents

SULPHONAMIDE COMPOUNDS THAT MODULATE CHEMOKINE RECEPTOR ACTIVITY (CCR4)

The invention relates to sulphonamide compounds, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.